Armotraz

• Anastrozole is indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer.

• Anastrozole is indicated for the first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer. 

• Anastrozole is indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with ER-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to Anastrozole.

Each box contains 20 strips of ten tablets in a single individual box.

Other brands available are

Altraz mfg by Alkem Laboratories